Activity of isoflavans of Dalea aurea (Fabaceae) against the opportunistic ameba Naegleria fowleri

Planta Medica

Volumn 72, Issue 4, 2006, Pages 383-386

  Belofsky, Gil ^a,c   Carreno, Roberto ^a   Goswick, Shannon M ^b   John, David T ^b  

^a UNIVERSITY OF TULSA   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c Efficas Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHOXYMANUIFOLIN K; AMPHOTERICIN B; ISOFLAVAN DERIVATIVE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DALEA AUREA; DRUG ISOLATION; DRUG STRUCTURE; EXPERIMENTAL MODEL; IN VITRO STUDY; LEGUME; MENINGOENCEPHALITIS; MOUSE; NAEGLERIA FOWLERI; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AMEBICIDES; AMOEBA; ANIMALS; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; DISEASE MODELS, ANIMAL; FABACEAE; ISOFLAVONES; MALE; MENINGOENCEPHALITIS; MICE; MICE, INBRED STRAINS; OPPORTUNISTIC INFECTIONS; PARASITIC SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS;

ANIMALIA; DALEA AUREA; FABACEAE; NAEGLERIA FOWLERI;

EID: 33645525847     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916252     Document Type: Article

References (16)

1. Belofsky G, French AN, Wallace DR, Dodson SR. New geranyl stilbenes from Dalea purpurea with in vitro opioid receptor affinity. J Nat Prod 2004; 67: 26-30
2. Belofsky G, Percivill D, Lewis K, Tegos GP, Ekart J. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod 2004; 67: 481-4
3. Hufford CD, Jia Y, Croom EM, Muhammed I, Okunade AL, Clark AM. Antimicrobial compounds from Petalostemum purpureum. J Nat Prod 1993; 56: 1878-89
4. Moerman DE. Native American ethnobotany. Portland: Timber Press Inc, 1998: p 192
5. John DT. In: Kreier JP, Baker JR, editors. Parasitic protozoa.; 2nd edition, Vol. 3 San Diego: Academic Press Inc, 1993: p 143-246
6. Apley JS, Clarke SK, Roome AP, Sandry SA, Saygi G, Silk B et al. Primary amebic meningoencephalitis in Britain. Br Med J 1970; 1: 596-9
7. Wang A, Kay R, Poon WS, Ng HK. Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong. Clin Neurol Neurosurg 1993; 95: 249-52
8. Stevens AR, Shulman ST, Lansen TA, Cichon MJ, Willaert E. Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis 1981; 143: 193-9
9. Goswick SM, Brenner GM. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. Antimicrob Agents Chemother 2003; 47: 524-8
10. Goswick SM, Brenner GM. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. J Parasitol 2003; 89: 837-42
11. Zeng JF, Wei HX, Li GL, Zhu DY. Three prenylated isoflavans from Maackia tenuifolia. Phytochemistry 1998; 47: 903-5
12. Jha HC, Zilliken F, Breitmaier E. Carbon-13 chemical shift assignments of chromones and isoflavones. Can J Chem 1980; 58: 1211-9
13. Rama Murthy MS, Rao EV, Ward RS. Carbon-13 nuclear magnetic resonance spectra of isoflavones. Magn Reson Chem 1986; 24: 225-30
14. Versteeg M, Bezuidenhoudt BCB, Ferreira D. Stereoselective synthesis of isoflavanoids. (R)- and (S)-isoflavans. Tetrahedron 1999; 55: 3365-76
15. Martinez AJ, Nelson EC, Duma RJ. Animal model: primary amebic (Naegleria) meningoencephalitis in mice. Am J Pathol 1973; 73: 545-8
16. John DT, Weik RR, Adams AC. Immunization of mice against Naegleria fowleri infection. Infect Immun 1977; 16: 817-20